PARNAX LAB LIMITED

PARNAXLAB.BO
Exchange BSE, Currency in INR
Loading price...

Overview

Previous Close--
Open--
Ask--
Bid--
Day's Range -
52 Week Range -
PE Ratio(TTM)--
Market Cap--
Volume₹NaN
Avg. Volume₹NaN
Face Value₹NaN
Dividend Yield--

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

Important Ratios

PARTICULARS20192020202120222023
Net Sales₹6₹8₹2₹7₹7
Total Expenditure₹6₹7₹3₹6₹6
Raw Materials₹3₹4₹1₹4₹3
Employees₹0₹1₹0₹1₹1
Selling, Administration Expenses₹1₹1₹0₹0₹1
Power and Fuel Cost₹0₹0₹0₹0₹0
Operating Profits₹0₹1-₹0₹1₹2
OPM%1.695%6.901%-19.409%19.161%21.017%
Other Income₹1₹0₹0₹0₹0
Depreciation₹0₹0₹0₹0₹0
Interest₹1₹1₹1₹1₹0
Profit Before Tax-₹1-₹0-₹1₹1₹2
Tax₹0₹2-₹0₹0₹0
Profit After Tax-₹1-₹2-₹1₹1₹1
Adjusted EPS-₹1-₹2-₹1₹1₹1
Net Profit Margin-12.79%-26.04%-47.68%7.55%16.06%

Company Profile

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Mumbai, India
Website: https://www.naxparlab.com
MD & CEO: Mr. Mihir Prakash Shah
About Company:
Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provides drug identification and development services; in- and out-licensing services; and contract research and manufacturing services The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.